SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,688.94 |
| Enterprise Value ($M) | 3,172.75 |
| Book Value ($M) | 338.97 |
| Book Value / Share | 2.73 |
| Price / Book | 7.93 |
| NCAV ($M) | -475.39 |
| NCAV / Share | -3.82 |
| Price / NCAV | -5.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.54 |
| Return on Assets (ROA) | -0.70 |
| Return on Equity (ROE) | -1.88 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.72 |
| Current Ratio | 0.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 69.40 |
| Assets | 883.76 |
| Liabilities | 544.78 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Avoro Capital Advisors LLC | 7.20 | ||
| 13G/A | State Street Corp | 5.10 | -6.90 | |
| 13G/A | Vanguard Group Inc | 10.01 | 16.23 | |
| 13G/A | BlackRock Inc. | 12.40 | 4.66 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 189,409 | 940,864 | 20.13 | |
| 173,025 | 749,066 | 23.10 | |
| 104,070 | 593,841 | 17.52 | |
| 156,853 | 988,598 | 15.87 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APLS – Apellis Pharmaceuticals, Inc. | ARQT – Arcutis Biotherapeutics, Inc. |
| ARVN – Arvinas, Inc. | ASMB – Assembly Biosciences, Inc. |
| ATHA – Athira Pharma, Inc. |